Omalizumab - therapeutic perspective in the treatment of severe asthma

Abstract

The application of monoclonal antibody reacting with IgE (omalizumab) could improve clinical presentation of patients suffering from persistent allergic asthma. Mechanisms of omalizumab activity and its clinical inducations are shown.

Keywords

• bronchial asthma
• omalizumab (anti-IgE antibody)